CAD and hereditary cancer: Whilst determining which children could be carrier of a CPS-associated variant remains a major challenge for the pediatric oncologists, the rapidly and constantly changing landscape in the field of hereditary cancer suggests that a careful evaluation of the optimal diagnostic strategy is paramount to providing timely recognition of CPS and at the same time avoiding unnecessary testing and uncertain results.